chevron_leftBack
As of 21 June 2026, Quest Laboratories Ltd. has a market cap of $25.24M USD, ranking #35444 globally and #2461 in India.
It ranks #3205 in the Healthcare sector, and #1080 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$25.24MUSD
2.38B INR
Enterprise Value
$28.67MUSD
2.71B INR
Revenue (TTM)
$13.34MUSD
1.26B INR
EBITDA (TTM)
$2.57MUSD
242.73M INR
Net Income (TTM)
$2.27MUSD
213.89M INR
EBITDA Margin
19%
Profit Margin
17%
PE Ratio
14.7
PS Ratio
1.9
PB Ratio
2.6
EV/EBITDA
11.2
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Anil Sabarwal
open_in_new
Employees
50
Founded
1994
Website
questlabltd.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 5% | 26% | 34% | 47% | 63% | 30% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
QUESTLAB
Quest Laboratories Ltd
ISIN: INE0TNW01017
Shares Out.:
Shares Outstanding:
16.387M1
Shares Float:
5.044M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
152.55 INR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Quest Laboratories Ltd.
Quest Laboratories Limited manufactures and sells pharmaceutical formulations in India. The company offers ethical drugs, generic drugs, and over the-counter drugs under various categories, such as antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and others. It provides its products in various forms, such as tablets, liquid orals, oral dry powders, oral powders, ointments, external liquids, and oral suspension. The company also engages in contract manufacturing activities for pharmaceutical companies. Quest Laboratories Limited was founded in 1994 and is based in Dhar, India.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NSE: SUNPHARMA
|
$45.22B
179K%
4.27T INR
|
39.1
|
|
NSE: DIVISLAB
|
$18.38B
73K%
1.73T INR
|
70.0
|
|
NSE: TORNTPHARM
|
$15.17B
60K%
1.43T INR
|
63.0
|
|
NSE: DRREDDY
|
$11.73B
46K%
1.11T INR
|
19.6
|
|
NSE: MANKIND
|
$9.87B
39K%
931.67B INR
|
52.2
|
|
NSE: ZYDUSLIFE
|
$9.71B
38K%
916.53B INR
|
18.6
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
3M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
2M%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
1M%
|
97.4
|
|
SIX: RO
|
$318.3B
1M%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$284.64B
1M%
215.59B GBP
|
27.6
|
|
NYSE: MRK
|
$274.03B
1M%
|
15.1
|
chevron_leftBack